Raymond James Financial Services Advisors’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $90.9K | Hold |
60,591
| – | – | ﹤0.01% | 3288 |
|
|
2024
Q2 | $42.6K | Hold |
60,591
| – | – | ﹤0.01% | 3297 |
|
|
2024
Q1 | $57.6K | Hold |
60,591
| – | – | ﹤0.01% | 3274 |
|
|
2023
Q4 | $67.3K | Sell |
60,591
-1,340
| -2% | -$1.49K | ﹤0.01% | 3158 |
|
|
2023
Q3 | $116K | Hold |
61,931
| – | – | ﹤0.01% | 3034 |
|
|
2023
Q2 | $222K | Buy |
61,931
+438
| +0.7% | +$1.57K | ﹤0.01% | 2856 |
|
|
2023
Q1 | $207K | Sell |
61,493
-997
| -2% | -$3.36K | ﹤0.01% | 2880 |
|
|
2022
Q4 | $96.9K | Buy |
62,490
+1,151
| +2% | +$1.78K | ﹤0.01% | 3010 |
|
|
2022
Q3 | $83K | Buy |
61,339
+362
| +0.6% | +$490 | ﹤0.01% | 3011 |
|
|
2022
Q2 | $134K | Buy |
60,977
+3,293
| +6% | +$7.24K | ﹤0.01% | 2949 |
|
|
2022
Q1 | $184K | Buy |
57,684
+10,141
| +21% | +$32.3K | ﹤0.01% | 2983 |
|
|
2021
Q4 | $199K | Buy |
+47,543
| New | +$199K | ﹤0.01% | 2975 |
|